Há cinquenta anos, a Excisão Total do Mesorreto (ETM) transformou a cirurgia do cancro do reto e, com ela, as taxas de recidiva local, a sobrevivência e a qualidade de vida de doentes em todo o mundo.
Nos dias 22 e 23 de maio de 2026, a International Rectal Cancer Meeting - “50 Years of Total Mesorectal Excision: Celebrating the Legacy of Bill Heald” reunirá, no Centro Champalimaud em Lisboa, especialistas de referência para assinalar este marco e refletir sobre o futuro.
Data e hora
11 de abril, 2026, 11:00-18:00 WEST
Local
Auditório, Fundação Champalimaud, Lisboa
Sobre
A conferência incluirá sessões científicas, debates e depoimentos de pacientes, reunindo jovens investigadores, especialistas de renome, pacientes e familiares para uma discussão abrangente nas áreas da neurociência e da doença de Parkinson.
Alguns dos temas discutidos serão, a inteligência artificial em medicina, a investigação em doenças do movimento e desafios de viver com Parkinson.
Ana Luísa Correia, Cancer Dormancy & Immunity
Klaas van Gisbergen, Tissue Immunity
Leopoldo Petreanu, Cortical Circuits
Adriana Sánchez Danés, PhD, Cancer and Stem Cell Biology Lab
Seminar room
In this seminar, I will present recent advances developed in our laboratory in CAR-based adoptive T-cell immunotherapy, with a particular focuss on leukemia. The talk will highlight γδ T cells as allogeneic effector platforms and explore emerging dual-targeting and armored CAR strategies.
Location and Dates: Champalimaud Foundation, 13 to 17 April 2026
Application Deadline: 22 February 2026
Acceptance Notification: 24 February 2026
Cost: 300 Euros + VAT (23%) (payment deadline 2 March 2026). The fee includes coffee-breaks, lunches and the course dinner on 16 April 2026.
Candidate Attendance Confirmation Deadline: 2 March
Capacity: 16 participants
The first edition of the Botton-Champalimaud International Pancreatic Conference, hosted at the prestigious Botton-Champalimaud Pancreatic Cancer Centre, was a landmark event in 2024, bringing together leading experts, researchers, and healthcare professionals from around the world to discuss the latest advancements in pancreatic cancer diagnosis, treatment, and care.
The symposium, themed "Neural and Immune Codes in Cancer" will gather an interdisciplinary community of researchers to discuss the interplay between the neural and immune systems in relation to cancer initiation, progression, defense and therapy. This symposium will emphasise the dynamic interactions among tumour cells, neurons and immune components, and how these relationships impact tumour growth, metastasis and the tumour microenvironment.